Colgate-Palmolive (NYSE:CL) Shares Acquired by Mather Group LLC.

Mather Group LLC. boosted its stake in Colgate-Palmolive (NYSE:CL) by 33.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,968 shares of the company’s stock after buying an additional 2,245 shares during the period. Mather Group LLC.’s holdings in Colgate-Palmolive were worth $808,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of CL. Norges Bank acquired a new stake in Colgate-Palmolive in the fourth quarter worth about $731,843,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Colgate-Palmolive by 27.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares during the period. Swedbank AB acquired a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $286,370,000. Magellan Asset Management Ltd raised its holdings in Colgate-Palmolive by 4,162.6% during the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock worth $160,718,000 after purchasing an additional 1,968,988 shares in the last quarter. Finally, Confluence Investment Management LLC acquired a new stake in Colgate-Palmolive in the first quarter worth approximately $130,622,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $1.17 during mid-day trading on Wednesday, reaching $103.83. 1,140,149 shares of the stock were exchanged, compared to its average volume of 4,426,322. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90. The company has a market cap of $85.19 billion, a price-to-earnings ratio of 32.48, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $104.15. The firm has a 50-day simple moving average of $96.85 and a 200 day simple moving average of $91.20.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business’s revenue was up 4.9% on a year-over-year basis. During the same period last year, the firm posted $0.77 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.93%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Analysts Set New Price Targets

A number of research firms have recently commented on CL. Stifel Nicolaus boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. Argus lifted their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Wells Fargo & Company increased their target price on Colgate-Palmolive from $92.00 to $97.00 and gave the company an “equal weight” rating in a report on Wednesday, July 10th. Bank of America lifted their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, TD Cowen increased their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $101.11.

Insider Activity at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.